Skip to main content

Advertisement

SpringerLink
Log in

Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Adiponectin is a fat-derived hormone produced and secreted exclusively by adipocytes that have anti-atherosclerotic effects. The aim of this study was to evaluate the relationship between fasting serum adiponectin levels and arterial stiffness among kidney transplant (KT) patients.

Methods

Fasting blood samples were obtained from 69 KT patients. Brachial–ankle pulse wave velocity (baPWV) was measured in the right or left brachial artery to the ankle segments using an automatic pulse wave analyzer. Plasma adiponectin levels were measured using a commercial enzyme-linked immunosorbent assay kit. Left or right baPWV values of >14.0 m/s were used to define the high arterial stiffness group.

Results

Thirty-five KT patients (35/69; 50.7 %) were defined in high arterial stiffness group. Diabetes (P = 0.013), smoking (P = 0.001), KT duration (P < 0.001), body weight (P = 0.013), waist circumference (P = 0.013), body mass index (P = 0.001), fasting glucose (P = 0.013), systolic blood pressure (P < 0.001), diastolic blood pressure (P = 0.008), and pulse pressure (P = 0.003) were higher, while serum adiponectin level (P = 0.004) was lower in high arterial stiffness group compared with low arterial stiffness group. Multivariate logistic regression analysis showed that adiponectin (odds ratio 0.90, 95 % confidence interval 0.81–0.99, P = 0.034) was still the independent predictors of arterial stiffness among the KT patients.

Conclusion

Serum fasting adiponectin level was inversely associated with arterial stiffness among KT patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cavalcante JL, Lima JA, Redheuil A, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511–22.

    Article  PubMed  Google Scholar 

  2. Liefeldt L, Budde K. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transpl Int. 2010;23:1191–204.

    Article  PubMed  Google Scholar 

  3. Khoshdel AR, Carney SL. Arterial stiffness in kidney transplant recipients: an overview of methodology and applications. Urol J. 2008;5:3–14.

    PubMed  Google Scholar 

  4. Verbeke F, Maréchal C, Van Laecke S, et al. Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension. 2011;58:833–8.

    Article  CAS  PubMed  Google Scholar 

  5. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J. 2010;74:24–33.

    Article  PubMed  Google Scholar 

  6. Tanaka H, Munakata M, Kawano Y, et al. Comparison between carotid–femoral and brachial–ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022–7.

    Article  CAS  PubMed  Google Scholar 

  7. Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, et al. Prediction of cardiovascular events and all-cause mortality with brachial–ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60:556–62.

    Article  CAS  PubMed  Google Scholar 

  8. Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006;27:762–78.

    Article  CAS  PubMed  Google Scholar 

  9. Windham BG, Griswold ME, Farasat SM, et al. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. Am J Hypertens. 2010;23:501–7.

    Article  CAS  PubMed  Google Scholar 

  10. Sung SH, Chuang SY, Sheu WH, et al. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol. 2009;103:1411–6.

    Article  CAS  PubMed  Google Scholar 

  11. Kawamoto R, Tabara Y, Kohara K, et al. Serum high molecular weight adiponectin correlates with arterial stiffness in community-dwelling persons. Endocr Res. 2011;36:53–63.

    Article  CAS  PubMed  Google Scholar 

  12. Youn JC, Kim C, Park S, et al. Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol. 2013;163:316–9.

    Article  PubMed  Google Scholar 

  13. Lee MC, Lee CJ, Ho GJ, et al. Hyperleptinemia positively correlated with metabolic syndrome in renal transplant recipients. Clin Transplant. 2010;24:E124–9.

    Article  PubMed  Google Scholar 

  14. Lee MC, Lee CJ, Ho GJ, et al. Fasting adiponectin correlates inversely with metabolic syndrome in kidney transplantation patients. Transplant Proc. 2011;43:2601–5.

    Article  CAS  PubMed  Google Scholar 

  15. Hsu BG, Ho GJ, Lee CJ, et al. Inverse association of serum long-acting natriuretic peptide and bone mass density in renal transplant recipients. Clin Transplant. 2012;26:E105–10.

    Article  CAS  PubMed  Google Scholar 

  16. Kubozono T, Miyata M, Ueyama K, et al. Acute and chronic effects of smoking on arterial stiffness. Circ J. 2011;75:698–702.

    Article  PubMed  Google Scholar 

  17. Kato A, Ishida J, Endo Y, et al. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrol Dial Transplant. 2011;26:1967–76.

    Article  PubMed  Google Scholar 

  18. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006;82:603–11.

    Article  PubMed  Google Scholar 

  19. Svensson M, Jardine A, Fellström B, et al. Prevention of cardiovascular disease after renal transplantation. Curr Opin Organ Transplant. 2012;17:393–400.

    PubMed  Google Scholar 

  20. Strózecki P, Adamowicz A, Włodarczyk Z, et al. Factors associated with increased arterial stiffness in renal transplant recipients. Med Sci Monit. 2010;16:CR301–6.

    PubMed  Google Scholar 

  21. Mitchell A, Opazo Saez A, Kos M, et al. Pulse wave velocity predicts mortality in renal transplant patients. Eur J Med Res. 2010;15:452–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Strozecki P, Adamowicz A, Kozlowski M, et al. Progressive arterial stiffening in kidney transplant recipients. Ann Transplant. 2011;16:30–5.

    CAS  PubMed  Google Scholar 

  23. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51:527–39.

    Article  CAS  PubMed  Google Scholar 

  24. Briet M, Boutouyrie P, Laurent S, et al. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82:388–400.

    Article  PubMed  Google Scholar 

  25. Opazo Saez A, Kos M, Witzke O, et al. Effect of new-onset diabetes mellitus on arterial stiffness in renal transplantation. Transpl Int. 2008;21:930–5.

    Article  PubMed  Google Scholar 

  26. Sutton-Tyrrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429–33.

    Article  CAS  PubMed  Google Scholar 

  27. Hirai T, Okuno A, Souda T, et al. Evaluation of arterial stiffness after successful renal transplantation using brachial–ankle pulse wave velocity. Transplant Proc. 2010;42:4061–3.

    Article  CAS  PubMed  Google Scholar 

  28. Lee M, Choh AC, Demerath EW, et al. Associations between trunk, leg and total body adiposity with arterial stiffness. Am J Hypertens. 2012;25:1131–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Xu A, Vanhoutte PM. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2012;302:H1231–40.

    Article  CAS  PubMed  Google Scholar 

  30. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.

    Article  CAS  PubMed  Google Scholar 

  31. Ikonomidis I, Kadoglou N, Tsiotra PC, et al. Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens. 2012;25:746–55.

    Article  CAS  PubMed  Google Scholar 

  32. de Faria AP, Demacq C, Figueiredo VN, et al. Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. Hypertens Res. 2013;36:1067–72.

    Article  PubMed  Google Scholar 

  33. El Khoudary SR, Barinas-Mitchell E, White J, et al. Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men. Atherosclerosis. 2012;225:475–80.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Kato K, Matsuhisa M, Ichimaru N, et al. The impact of new-onset diabetes on arterial stiffness after renal transplantation. Endocr J. 2008;55:677–83.

    Article  PubMed  Google Scholar 

  35. Joannidès R, Monteil C, de Ligny BH, et al. Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant. 2011;11:2414–22.

    Article  PubMed  Google Scholar 

  36. Gungor O, Kircelli F, Carrero JJ, et al. The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients. Clin Nephrol. 2011;75:491–6.

    Article  CAS  PubMed  Google Scholar 

  37. Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221:18–33.

    Article  CAS  PubMed  Google Scholar 

  38. Vyssoulis GP, Karpanou EA, Kyvelou SM, et al. Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking. J Clin Hypertens. 2008;10:201–7.

    Article  Google Scholar 

  39. Koumaras C, Tziomalos K, Stavrinou E, et al. Effects of renin–angiotensin–aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens. 2014;8:74–82.

    Article  CAS  PubMed  Google Scholar 

  40. Becker B, Kronenberg F, Kielstein JT, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005;16:1091–8.

    Article  CAS  PubMed  Google Scholar 

  41. Iwashima Y, Horio T, Kumada M, et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006;98:1603–8.

    Article  CAS  PubMed  Google Scholar 

  42. Nishimura M, Hashimoto T, Kobayashi H, et al. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients. Nephrol Dial Transplant. 2006;21:1640–7.

    Article  CAS  PubMed  Google Scholar 

  43. Abdallah E, Waked E, Nabil M, et al. Adiponectin and cardiovascular outcomes among hemodialysis patients. Kidney Blood Press Res. 2012;35:247–53.

    Article  CAS  PubMed  Google Scholar 

  44. Roos M, Baumann M, Liu D, et al. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study. Regul Pept. 2012;178:11–5.

    Article  CAS  PubMed  Google Scholar 

  45. Cañas L, Bayés B, Granada ML, et al. Is adiponectin a marker of preclinical atherosclerosis in kidney transplantation? Clin Transplant. 2012;26:259–66.

    Article  PubMed  Google Scholar 

  46. Menon V, Li L, Wang X, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2599–606.

    Article  CAS  PubMed  Google Scholar 

  47. Ohashi N, Kato A, Misaki T, et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med. 2008;47:485–91.

    Article  PubMed  Google Scholar 

  48. Alam A, Molnar MZ, Czira ME, et al. Serum adiponectin levels and mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013;8:460–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Sattar N, Wannamethee G, Sarwar N, et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006;114:623–9.

    Article  CAS  PubMed  Google Scholar 

  50. Hao G, Li W, Guo R, et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. Atherosclerosis. 2013;228:29–35.

    Article  CAS  PubMed  Google Scholar 

  51. Kanhai DA, Kranendonk ME, Uiterwaal CS, et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies. Obes Rev. 2013;14:555–67.

    Article  CAS  PubMed  Google Scholar 

  52. SookLee E, Park SS, Kim E, et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epodemiol. 2013;42:1029–39.

    Article  Google Scholar 

  53. Wu Z, Cheng Y, Aung LH, et al. Association between adiponectin concentrations and cardiovascular disease in diabetic patients: a systematic review and meta-analysis. PLoS ONE. 2013;8:e78485.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Wu ZJ, Cheng YJ, Gu WJ, et al. Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: a systematic review and meta-analysis. Metabolism. 2014 (in press).

  55. Nanayakkara PW, Le Poole CY, Fouque D, et al. Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3–5 chronic kidney disease. Clin Nephrol. 2009;72:21–30.

    Article  CAS  PubMed  Google Scholar 

  56. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from Buddhist Tzu Chi General Hospital, Hualien, Taiwan (TCRD101-06).

Conflict of interest

All the authors have declared that there are no conflicts of interests.

Author information

Authors and Affiliations

  1. Division of Nephrology, Buddhist Tzu Chi General Hospital, and School of Medicine, Tzu Chi University, No. 707, Section 3, Chung-Yang Raod, Hualien, Taiwan

    Bang-Gee Hsu

  2. Department of Surgery, Buddhist Tzu Chi General Hospital, Hualien, Taiwan

    Guan-Jin Ho & Yen-Cheng Chen

  3. Department of Surgery, Buddhist Tzu Chi General Hospital, and School of Medicine, Tzu Chi University, Hualien, Taiwan

    Ming-Che Lee

  4. Department of Nursing, Tzu Chi College of Technology, Hualien, Taiwan

    Chung-Jen Lee

Authors
  1. Guan-Jin Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming-Che Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chung-Jen Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yen-Cheng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bang-Gee Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bang-Gee Hsu.

Additional information

G. J. Ho and M. C. Lee contributed equally to this study.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ho, GJ., Lee, MC., Lee, CJ. et al. Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients. Clin Exp Nephrol 19, 534–541 (2015). https://doi.org/10.1007/s10157-014-1010-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-014-1010-1

Keywords

Search

Navigation